Centogene: Up as U.S. FDA grants emergency use for COVID-19 test

Crown LiquidationCo NV in liquidatie

19/10/2020 12:03

** U.S.-listed shares of Germany based diagnostic and pharma
co  CNTG.O  up 16% at $12.6 premarket; set for their best day in
7 months 
    ** U.S. FDA grants emergency use authorization for co's
COVID-19 test, CentoSure, for individuals without any symptoms
or suspicion of COVID-19  urn:newsml:reuters.com:*:nGNX85f8xN
    ** Co says CentoSure will support widespread testing for the
global population
    ** "Broad preventative testing is the best way to detect
SARS-CoV-2 infections and successfully preventing the next wave
of infections to effectively fight the COVID-19 pandemic" - Co
    ** Up to Friday's close, stock had risen ~8% YTD

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com;))